| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3383198 | Reumatología Clínica | 2012 | 7 Pages |
Abstract
The prevention of HF with alendronate in osteoporotic women > 64 years is cost-useful in the long term (20 years) with a low budgetary impact in the 75-79 year group.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
MarÃa J. Pueyo, Marta Larrosa, Xavier SurÃs, Antonio J. Garcia-Ruiz,